|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Corticotropin Releasing Factor (Plasma)
Test Code92100
CPT Codes
83519
Preferred Specimen
3 mL plasma collected in an EDTA (lavender-top) tube
Patient Preparation
Patient should be fasting 10-12 hours and should not be on any corticosteroid, ACTH, or estrogen medications, if possible, for at least 48 hours prior to collection of specimen. A morning specimen is preferred.
Minimum Volume
1 mL
Instructions
3 mL EDTA plasma should be collected and separated as soon as possible.
Plasma should be frozen immediately after separation.
Special specimens: For tumor/tissue and various fluids (i.e. CSF, peritoneal, synovial, etc.), contact the Institute for requirements and special handling. Ship specimens frozen in dry ice.
Plasma should be frozen immediately after separation.
Special specimens: For tumor/tissue and various fluids (i.e. CSF, peritoneal, synovial, etc.), contact the Institute for requirements and special handling. Ship specimens frozen in dry ice.
Transport Container
Transport tube
Transport Temperature
Frozen
Specimen Stability
Room temperature: 1 hour
Refrigerated: 24 hours
Frozen: 6 months
Refrigerated: 24 hours
Frozen: 6 months
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Serum will be rejected. This is a plasma only test.
Methodology
Direct Radioimmunoassay
FDA Status
This test was developed and its performance characteristics determined by Inter Science Institute. It has not been cleared or approved by the US Food and Drug Administration. The FDA has determined that such clearance is not necessary.
Setup Schedule
Set up: As received; Report Available: 15 days
Reference Range
See Laboratory Report
Clinical Significance
Corticotropin Releasing Factor is a 41 amino acid peptide produced in the hypothalamus. It stimulates the release of ACTH from the pituitary which in turn releases Cortisol from the adrenal gland. The Cortisol produced rapidly shuts off CRF secretion acting as a negative feedback control. CRF also releases b-Endorphin, b-Lipotropin and other related proopiomelanocortin peptides. Ectopic tumors producing ACTH also frequently produce CRF. In these patients ACTH usually does not respond to Dexamethasone suppression. CRF is markedly elevated in third trimester pregnancy. Most of it is produced by the placenta and is bound to CRF-Binding Protein and is biologically inactive. The CRF stimulation test is the most effective method of differentiating primary from secondary adrenal insufficiency and in differentiating hypothalamic from pituitary causes.
Performing Laboratory
Inter Science Institute
944 W Hyde Park Blvd
Inglewood, CA 90302